Scientists test supercharged immune cells against deadly brain cancer
NCT ID NCT07172178
Summary
This is an early safety study testing a new cell therapy for malignant meningioma, an aggressive type of brain tumor. Researchers will modify a patient's own immune cells to better fight the cancer and test different doses in a small group of 12 people. The main goal is to find a safe dose and see if the treatment shows any signs of helping control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT MENINGIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.